Loading...

ICSBP-mediated immune protection against BCR-ABL–induced leukemia requires the CCL6 and CCL9 chemokines

Interferon (IFN) is effective at inducing complete remissions in patients with chronic myelogenous leukemia (CML), and evidence supports an immune mechanism. Here we show that the type I IFNs (alpha and beta) regulate expression of the IFN consensus sequence-binding protein (ICSBP) in BCR-ABL–transf...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Nardi, Valentina, Naveiras, Olaia, Azam, Mohammad, Daley, George Q.
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Hematology 2009
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2670796/
https://ncbi.nlm.nih.gov/pubmed/19171873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-07-167189
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!